Ali, Faisal S.
Saint Joseph Hospital
4 papers on CoChatORCID 0000-0001-7372-5158
Most cited papers
- Verified
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study
Abu-Sbeih, H., Ali, F. S., Alsaadi, D., Jennings, J., Luo, W., Gong, Z., Richards, D. M., Charabaty, A., & Wang, Y. (2018) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersInflammatory Bowel Disease
Cited by 215
- Verified
Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis
Abu-Sbeih, H., Ali, F. S., Luo, W., Qiao, W., Raju, G. S., & Wang, Y. (2018) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersMicroscopic Colitis
Cited by 209
- Verified
Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis
Abu-Sbeih, H., Ali, F. S., Wang, X., Mallepally, N., Chen, E., Altan, M., Bresalier, R. S., Charabaty, A., Dadu, R., Jazaeri, A., et al. (2019) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersInflammatory Bowel Disease
Cited by 191
- Verified
Immune-checkpoint inhibitors induced diarrhea and colitis: a review of incidence, pathogenesis and management
Abu-Sbeih, H., Ali, F. S., & Wang, Y. (2020) · Current Opinion in Gastroenterology
Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions
Cited by 30
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free